Sun Pharma to acquire Daiichi's 11.28 percent stake in Zenotech MD Bureau22 March 2022 4:34 PM ISTAfter the acquisition, Sun Pharma's stake in Zenotech will increase from 57.56 percent to 68.84 percent.
Glenmark gets CDSCO panel nod for Phase 4 study of anti-diabetic FDC drug Dr. Divya Colin21 March 2022 6:37 PM ISTNew Delhi: In line with the drug major Glenmark Pharmaceutical's revised Phase IV clinical trial protocol for anti-diabetic fixed dose combination...
Present more data on unmet medical need for Tildrakizumab: CDSCO Panel tells Sun pharma Dr. Divya Colin20 March 2022 12:30 PM ISTNew Delhi: In response to the drug-major Sun Pharma's phase 3 protocol for immunomodulator Tildrakizumab, the Subject Expert Committee (SEC)...
COVID-19: 35 pharma cos to mass product generic version of Pfizer's Paxlovid MD Bureau18 March 2022 6:16 PM ISTIn India, Hyderabad-based pharma major Aurobindo Pharma has signed the agreement.
GSK gets CDSCO panel okay to conduct study on antineoplastic drug Belantamab Mafadotin Dr. Divya Colin18 March 2022 2:05 PM ISTNew Delhi: In a significant development, GSK Pharmaceuticals ( India) has got approval from the Subject Expert Committee (SEC) of the Central Drug...
39 drug samples including Glenmark Telma H fail to clear CDSCO test, 1 declared misbranded Susmita Roy17 March 2022 3:21 PM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, the Central Drugs Standard Control Organization (CDSCO), has flagged 39...
Natco Pharma gets CDSCO nod to manufacture, market anti neoplastic drug Idelalisib Dr. Divya Colin16 March 2022 6:52 PM ISTNew Delhi: In a significant development, Natco Pharma has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard Control...
NPPA Panel fixes retail price of antibiotic FDC marketed by Abbott, details Dr. Divya Colin15 March 2022 6:17 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) panel has fixed the retail price of modified released tablet containing cefixime,...
Bristol Myers Squibb Nivolumab marketing approval to be revoked for hepatocellular carcinoma: CDSCO panel Dr. Divya Colin14 March 2022 6:30 PM ISTNew Delhi: In a major setback for Bristol Myers Squibb, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
Unethical Marketing Practices Of Pharma Companies: SC to examine UCPMP code implementation Medical Dialogues Bureau12 March 2022 12:34 PM IST"No enforceable law exists which regulates the promotion of drugs by pharmaceutical companies vis-Ã -vis healthcare professionals, and therefore...
Setback: GSK proposal to market Meningococcal group B Vaccine rejected by CDSCO panel Dr. Divya Colin11 March 2022 5:08 PM ISTNew Delhi: In the major setback to GSK, citing that the firm has not submitted any safety and immunogenicity data in Indian population, the Subject...
Roche India Atezolizumab marketing approval to be revoked for two indications: CDSCO panel Susmita Roy10 March 2022 6:50 PM ISTNew Delhi: In a major setback to Roche Products (India), the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO)...
